Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 2/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.34 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.34 |
| ▸ | CXCR2 | P25025 | 7/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 2/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.31 |
| ▸ | HRH1 | P35367 | 2/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | DRD3 | P35462 | 2/20 | 0.31 |
| ▸ | HTR2B | P41595 | 2/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5718466 | 1.00 | NR3C1 (0.34) | NR3C1PGRNR3C2CXCR2CYP2C9 | |
| SCHEMBL1561187 | 1.00 | NR3C1 (0.34) | NR3C1PGRNR3C2CXCR2CYP2C9 | |
| Bromide SCHEMBL4625572 | 0.99 | CXCR2 (0.34) | NR3C1PGRNR3C2CXCR2CYP2C9 | |
| SCHEMBL5718374 | 0.84 | CXCR2 (0.34) | NR3C1PGRNR3C2CXCR2CYP2C9 | |
| SCHEMBL1361412 | 0.82 | CXCR2 (0.34) | NR3C1PGRNR3C2CXCR2CYP2C9 | |
| SCHEMBL4970687 | 0.77 | NR1H3 (0.32) | CXCR2 | |
| SCHEMBL29414628 | 0.72 | BCL2 (0.42) | NR3C1PGRNR3C2CYP2C9SLC6A4 | |
| SCHEMBL29414619 | 0.72 | BCL2 (0.42) | NR3C1PGRNR3C2CYP2C9SLC6A4 | |
| SCHEMBL907577 | 0.72 | BCL2 (0.42) | NR3C1PGRNR3C2CYP2C9SLC6A4 | |
| SCHEMBL679 | 0.72 | BCL2 (0.42) | NR3C1PGRNR3C2CYP2C9SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010004575-A2 | PREPARATION OF ESCITALOPRAM, ITS SALTS AND INTERMEDIATES | SHODHANA LABORATORIES LIMITED (IN) | 2010-01-14 | — | — | WO | claimed |
| JP-4377219-B2 | — | — | 2009-12-02 | — | — | JP | claimed |
| EP-2061753-A1 | METHOD FOR MANUFACTURE OF ESCITALOPRAM | H.Lundbeck A/S (DK) | 2009-05-27 | — | — | EP | claimed |
| WO-2009033488-A1 | METHOD FOR MANUFACTURE OF ESCITALOPRAM | H. LUNDBECK A/S (DK) | 2009-03-19 | — | — | WO | claimed |
| WO-2008059514-A2 | PROCESS FOR PREPARING ESCITALOPRAM | CADILA HEALTHCARE LIMITED (IN) | 2008-05-22 | — | — | WO | claimed |
| EP-1797060-A2 | \"PROCESS FOR PREPARATION OF CITALOPRAM AND ENANTIOMERS\ | Sun Pharmaceutical Industries Limited (IN) | 2007-06-20 | — | — | EP | claimed |
| EP-1732514-A1 | CRYSTALLINE COMPOSITION CONTAINING ESCITALOPRAM OXALATE | H. LUNDBECK A/S (DK) | 2006-12-20 | — | — | EP | claimed |
| WO-2006021971-A2 | 'PROCESS FOR PREPARATION OF CITALOPRAM AND ENANTIOMERS' | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2006-03-02 | — | — | WO | claimed |
| WO-2005084643-A1 | CRYSTALLINE COMPOSITION CONTAINING ESCITALOPRAM OXALATE | H. LUNDBECK A/S (DK) | 2005-09-15 | — | — | WO | claimed |
| JP-2004536093-A | — | — | 2004-12-02 | — | — | JP | claimed |
| EP-1412341-A1 | PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM AND/OR S- OR R-CITALOPRAM BY SEPARATION OF A MIXTURE OF R- AND S-CITALOPRAM | H. Lundbeck A/S (DK) | 2004-04-28 | — | — | EP | claimed |
| WO-2003000672-A1 | PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM AND/OR S- OR R-CITALOPRAM BY SEPARATION OF A MIXTURE OF R- AND S-CITALOPRAM | H. LUNDBECK A/S (DK) | 2003-01-03 | — | — | WO | claimed |
| WO-2010004575-A2 | PREPARATION OF ESCITALOPRAM, ITS SALTS AND INTERMEDIATES | SHODHANA LABORATORIES LIMITED (IN) | 2010-01-14 | — | — | WO | disclosed |
| WO-2009147687-A2 | AN IMPROVED PROCESS FOR THE SEPARATION OF ENANTIOMERICALLY PURE COMPOUNDS | SHODHANA LABORATORIES LIMITED (IN) | 2009-12-10 | — | — | WO | disclosed |
| EP-2061753-A1 | METHOD FOR MANUFACTURE OF ESCITALOPRAM | H.Lundbeck A/S (DK) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008059514-A3 | PROCESS FOR PREPARING ESCITALOPRAM | CADILA HEALTHCARE LTD (IN) | 2009-04-02 | — | — | WO | disclosed |
| WO-2003000672-A1 | PROCESS FOR THE PREPARATION OF RACEMIC CITALOPRAM AND/OR S- OR R-CITALOPRAM BY SEPARATION OF A MIXTURE OF R- AND S-CITALOPRAM | H. LUNDBECK A/S (DK) | 2003-01-03 | — | — | WO | disclosed |
| EP-1228056-A2 | METHOD FOR THE PREPARATION OF CITALOPRAM | H. LUNDBECK A/S (DK) | 2002-08-07 | — | — | EP | disclosed |
| WO-2000012044-A2 | METHOD FOR THE PREPARATION OF CITALOPRAM | H. LUNDBECK A/S (DK) | 2000-03-09 | — | — | WO | disclosed |
| EP-0171943-B1 | NOVEL INTERMEDIATE AND METHOD FOR ITS PREPARATION | H. LUNDBECK A/S (DK) | 1988-11-17 | — | — | EP | disclosed |